Autopsy report · NCT05144334
A Study of BTX-1188 in Subjects With Advanced Malignancies
Cause of deathFunding or business
“Business decision”
Life of this trial
- Registered 2 months before it started.
- Ran for about 1 year 8 months before it stopped.
- 8 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Biotheryx, Inc.
- Sponsor type
- Industry
- Conditions
- Advanced Solid Tumor; Non Hodgkin Lymphoma; Acute Myeloid Leukemia
- Interventions
- BTX-1188
- Participants
- 8
- Sites
- 4
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.